| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | United Kingdom | 5 | |
| #3 | Canada | 1 | |
| #4 | EPO (European Patent Office) | 1 | |
| #5 | Hong Kong | 1 | |
| #6 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Measuring microorganism processes | |
| #4 | Therapeutic chemical compounds | |
| #5 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wilmut Ian | 11 |
| #2 | Campbell Keith Henry Stockman | 9 |
| #3 | Haley Christopher Simon | 3 |
| #4 | Archibald Alan Langskill | 3 |
| #5 | Horvat Simon | 1 |
| #6 | Felmer Ricardo | 1 |
| #7 | Clark Anthony John | 1 |
| #8 | Wolf C Roland | 1 |
| #9 | Mcevoy Thomas Gerard | 1 |
| #10 | Clark A John | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2008152632A1 | Promoter-reporter cells for determining drug metabolism, drug interactions, and the effects of allotype variation | |
| US2003186437A1 | Use of RAIDD to control cell differentiation | |
| US2002124277A1 | Ungulates produced by nuclear transfer of G1 cells | |
| GB9824304D0 | Quiescent cell populations for nuclear transfer | |
| GB9926730D0 | Unactivated oocytes as cytoplast recipients for nuclear transfer |